Oramed Pharmaceuticals sell Biotechhunter
Start price
19.08.20
/
50%
€3.19
Target price
24.08.20
-
Performance (%)
-2.20%
End price
24.08.20
€3.12
Summary
This prediction ended on 24.08.20 with a price of €3.12. With a performance of -2.20%, the SELL prediction by Biotechhunter was trending in the right direction. Biotechhunter has 50% into this predictionOramed is a pharmaceutical company that focuses on the development of innovative oral delivery solutions for drugs that are traditionally administered through injection. The company is primarily dedicated to the development of an oral insulin capsule that can potentially revolutionize the treatment of diabetes. Their flagship product, ORMD-0801, is currently in Phase III clinical trials in the United States and has received Fast Track designation from the FDA. Oramed is a publicly traded company listed on the Nasdaq under the ticker symbol ORMP.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Oramed Pharmaceuticals | 1.039% | 1.039% | 3.584% | -76.312% |
| iShares Core DAX® | 2.594% | -1.861% | 13.242% | 16.867% |
| iShares Nasdaq 100 | 3.553% | -2.064% | 38.293% | 45.898% |
| iShares Nikkei 225® | 0.687% | -8.704% | 17.510% | 2.760% |
| iShares S&P 500 | 2.209% | -1.988% | 27.632% | 42.955% |
Comments by Biotechhunter for this prediction
In the thread Oramed Pharmaceuticals diskutieren
Sell Oramed Pharmaceuticals
In the thread Trading Oramed Pharmaceuticals
Stopped prediction by Biotechhunter for Oramed Pharmaceuticals
Oramed Pharmaceuticals
Start price
Target price
Perf. (%)
€2.15
28.10.20
28.10.20
-
04.11.21
04.11.21
433.02%
15.07.21
15.07.21
Oramed Pharmaceuticals
Start price
Target price
Perf. (%)
€2.65
10.09.20
10.09.20
-
17.09.20
17.09.20
-15.50%
17.09.20
17.09.20
Oramed Pharmaceuticals
Start price
Target price
Perf. (%)
€2.96
27.08.20
27.08.20
-
03.09.20
03.09.20
-10.47%
03.09.20
03.09.20
Oramed Pharmaceuticals
Start price
Target price
Perf. (%)
€3.57
16.07.20
16.07.20
-
01.08.20
01.08.20
-13.59%
01.08.20
01.08.20